The overall fluorescent microscope market size is approximately $550,000,000. Our target market is hospitals and clinicians who specialize in treating sepsis. Price estimate for our device: $480.

We will market our device to hospitals where fast and efficient diagnosis of diseases such as sepsis is needed.

Our estimated cost of goods sold to construct the device is $420. We plan to sell the fluorescent microscope portion of our device at $480, therefore resulting in a profit of $60 for each device sold. However, these estimated prices will increase after blood testing functionality of our device is added. Estimated cost per blood culture test: $780.

The market for fluorescence microscopes is expected to grow at a rate of 0.7%. Additionally, the number of these types of devices will be sold per year for our company will be approximately 5000 devices, based on estimates for number of devices sold for a specific disease such as sepsis. Assuming that we have ~1% of the market for our device, the growth rate of devices sold will be approximately: 5000*1% = 50 devices per year.

Thus:

Year 2023, Profit= $60*5050 = $303,000

Year 2024, Profit= $60*5100 = $306,000

Year 2025, Profit= $60*5150 = $309,000

etc.

We compared our device against three major criteria:

Cost- our device is a more affordable option to the current market.

Portability- design is portable, lightweight, and modular.

Efficiency- plugable USB camera operation is simple and has easily installable software.

Dino-lite

Photo by Dino-Lite

Olympus

Photo by Olympus on Microscope.com

AmScope

Photo by AmScope

Currently, our device functions only as a fluorescence microscope. As development of the device continues with Melio Labs and blood testing for sepsis functionality is added, we will encounter additional competitors in the blood testing market. The following companies are developing tests similar to our own: